The use of genetically modified animals has been studied in scientific research over time as a way to discover new treatments or even a cure for various diseases. Transgenic …
S de Brot, A Ntekim, R Cardenas… - Endocrine-related …, 2015 - erc.bioscientifica.com
Prostate cancer (PCa) is the most common malignancy affecting men in the western world. Although radical prostatectomy and radiation therapy can successfully treat PCa in the …
Background In recent times, anti-cancer treatments have focused on Fibroblast Growth Factor (FGF) and Vascular-Endothelial Growth Factor (VEGF) pathway inhibitors so as to …
F Montico, CA Lamas, IMU Rossetto… - Journal of molecular …, 2023 - Springer
Delayed cancer progression in the ventral prostate of the Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) model has been previously reported upon celecoxib and …
LA Kido, F Montico, R Sauce… - Endocrine-related …, 2016 - erc.bioscientifica.com
The aim of this study was to characterize the structural and molecular biology as well as evaluate the immediate and late responses of prostatic cancer in the transgenic …
V Figueroa, MS Rodríguez, C Lanari, CA Lamb - Steroids, 2019 - Elsevier
Dysregulation of the fibroblast growth factors/fibroblast growth factor receptor (FGF/FGFR) pathway has been implicated in a wide range of human disorders and several members …
GH Lee, HY Lee, L Zhao, MMU Rashid… - The World Journal …, 2024 - pmc.ncbi.nlm.nih.gov
Purpose Benign prostate hyperplasia (BPH) is a common age-related chronic condition. Its pathogenesis involves androgen imbalance, inflammation, oxidative stress, and …
PAM Mateus, LA Kido, RS Silva, VHA Cagnon… - The …, 2019 - Wiley Online Library
Background Chronic inflammation has been implicated in cancer etiology and angiogenesis is stimulated in this disease. In prostate, the crosstalk between malignant epithelial cells and …
BACKGROUND Prostate is highly affected by aging, which lead to inflammatory disorders that can predispose to cancer development. Chemoprevention has emerged as a new …